GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccin…

Biotechnology

US, Smyrna [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for GeoVax Labs, Inc.

GeoVax Labs, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

9,436,070

Volume

817,403

Volume on Avg.

1,710,600

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $2.25 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Dodd David A Internal : President, CEO	113,870	$256,207.50	04/25/23	P 32,000 x $0.64 = $20,480.00
Mckee Kelly T. Jr. Internal : Chief Medical Officer	4,999	$11,247.75	05/05/22	P 4,999 x $0.71 = $3,549.29
Newman Mark J Internal : Chief Scientific Officer	0	$0	08/14/23	0 x $0 = $0
Reynolds Mark Internal : CFO	68,184	$153,414.00	04/21/23	P 8,000 x $0.63 = $5,040.00
Sharkey John W. Internal : VP, Business Development	0	$0	08/14/23	0 x $0 = $0
Chase Randal D Internal : Director	0	$0	08/14/24	0 x $0 = $0
Kollintzas Dean G Internal : Director	0	$0	12/08/21	0 x $0 = $0
Lemerond Nicole Internal : Director	0	$0	09/06/22	0 x $0 = $0
Mcnally Robert T Internal : Director	0	$0	08/14/24	0 x $0 = $0
Morgan Jayne Internal : Director	0	$0	08/14/23	0 x $0 = $0
Spencer John N Jr Internal : Director	0	$0	08/14/24	0 x $0 = $0